Valye reports for unlimited access

1RT Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) incorporated in December 2024 in the Cayman Islands. Its sole purpose is to identify and complete an initial Business Combination with one or more target companies, primarily focusing on the digital assets and blockchain sectors. The company completed its Initial Public Offering in July 2025, raising gross proceeds of $172.5 million, which are held in a Trust Account. The company has not generated operating revenues and has not yet selected a Business Combination target. The management and advisory teams bring experience in digital assets, blockchain, and technology sectors, leveraging networks to source potential targets. The company must complete its Business Combination within 24 months of the IPO, by July 3, 2027, or liquidate and return funds to shareholders. The company’s acquisition criteria emphasize industry leaders with innovative technology, strong leadership, and proven business models, but it may consider other opportunities. The company’s financial position as of June 30, 2026, shows a current ratio of 1.54 and cash and equivalents of $36.2 million.

SPAR Group, Inc. is a Delaware corporation specializing in merchandising and brand marketing services primarily in the United States and Canada. With over 50 years of experience, the company provides a comprehensive suite of services designed to enhance retail sales and operational efficiency for retailers and consumer goods manufacturers. Its service offerings include merchandising and category management, retail remodel and transformation, assembly and installation, fulfillment and distribution, and business analytics and insights. The company operates from its headquarters in Charlotte, North Carolina, with local offices in the U.S. and Canada. SPAR Group serves a diverse client base across multiple retail and manufacturer markets, leveraging proprietary technology and a large network of merchandising specialists to deliver value. The company has a strategic focus on expanding its core business, introducing new services, and investing in technology to maintain competitive advantage and meet evolving market needs.

Analog Devices Inc is a semiconductor company operating in the Technology sector. It reports detailed financial results quarterly and annually through SEC filings. The company’s business includes multiple segments such as Industrial, Automotive, Communications, and Consumer. It maintains a strong liquidity position with a current ratio of 1.75 as of May 2, 2026. Recent financial results show significant net income and revenue growth. The company also pursues strategic acquisitions to expand its technology portfolio.

Hyperscale Data, Inc. is a Delaware-based holding company operating through multiple subsidiaries engaged in Bitcoin mining, AI data center hosting, defense solutions, commercial lending, and other diversified industries. The company is transitioning its data centers from Bitcoin mining to high-performance computing and AI-focused operations. It owns a broad portfolio of subsidiaries including Sentinum (crypto mining and AI hosting), Ault Capital Group (lending, blockchain, defense, real estate), and others. The company’s business model includes data center operations, AI ecosystem support, defense and aerospace products, commercial real estate, and fintech services. Major investment decisions are centralized under the Executive Committee.

KNOREX LTD. operates in the digital advertising technology sector, focusing on AI-powered solutions to optimize advertising campaigns across multiple channels. The company offers the XPO platform and the AI-powered XPO Optimizer, designed to improve advertising efficiency and reduce acquisition costs. It also provides an Agentic AI-Ready Ads API for cross-channel automation and white-label solutions for live commerce advertising. KNOREX targets large addressable markets, including an $80 billion market for its XPO Optimizer. The company has demonstrated measurable improvements in campaign performance, such as a 29% reduction in legal acquisition costs and increased conversion quality. KNOREX completed its initial public offering in 2025, raising approximately $12 million gross proceeds, which were allocated to consulting, debt repayment, product development, and working capital. The company is actively evolving its sales strategy to improve cost efficiency. Corporate governance includes a board of five directors with independent members and audit committee oversight. KNOREX maintains ISO/IEC 27001 certification and integrates cybersecurity risk management into its enterprise risk framework.

HeartCore Enterprises, Inc. was incorporated in 2021 and initially operated software development businesses in Japan, including customer experience management and digital transformation services. In 2025, the company strategically exited its software business to focus exclusively on its GO IPO consulting business, which assists Japanese companies with IPOs and listings on U.S. exchanges such as Nasdaq and NYSE. The consulting services cover introductions to legal and financial professionals, internal control documentation, accounting standard conversions, regulatory filings, translation, and investor relations support. The company receives compensation through cash fees and equity warrants from client companies. It leverages a relationship-driven sales approach targeting growth-stage Japanese enterprises and maintains partnerships with securities firms, legal advisors, and financial consultants. The company competes with global consultancies, boutique advisory firms, and investment bank advisory arms, emphasizing its niche specialization, integrated service offering, aligned compensation, and independence from auditors and underwriters. Recent strategic moves include establishing a subsidiary focused on digital securities consulting and divesting its majority interest in Sigmaways, resulting in revenue concentration among fewer clients. The company also faces Nasdaq minimum bid price compliance challenges [S1][S2].

Nakamoto Inc. is a Delaware corporation that transitioned from a patient-first healthcare company to a Bitcoin operating company following a reverse merger in August 2025. The company holds Bitcoin as a treasury reserve asset and invests in Bitcoin-native companies across finance, media, and advisory services. Nakamoto's Bitcoin Operations segment includes direct Bitcoin holdings, minority investments, and income-generating strategies such as options-writing. The Healthcare Operations segment provides patient-centered medical services focused on reducing opioid use and improving health outcomes but is planned to be exited. Key acquisitions include BTC Inc., a leading Bitcoin media and events company, and UTXO Management, an investment firm managing Bitcoin-focused funds. Nakamoto's Bitcoin holdings were approximately 5,342 Bitcoin valued at $467.5 million as of December 31, 2025. The company uses institutional-grade custodians and regulated exchanges for Bitcoin transactions. Revenue streams include patient care services, affiliate agreements, and product sales. As of June 30, 2026, Nakamoto reported $25.45 million in revenue and a net loss of $132.997 million, with liquidity ratios indicating limited short-term asset coverage of liabilities. The company maintains Nasdaq listing compliance after a reverse stock split and has a share repurchase program authorized.

Caring Brands, Inc. operates in the wellness consumer products sector, offering a range of OTC and cosmetic products addressing diverse health needs such as hair loss, skin conditions (eczema, psoriasis, vitiligo), and suncare protection. The company emphasizes clinical validation, patent protection, and commercial stability for its products. Key products include Photocil, a narrow band UV filter for vitiligo and psoriasis, and Hair Enzyme Booster (JW-700), designed to enhance minoxidil efficacy for hair loss treatment. The company has licensing agreements for manufacturing and marketing in India and other territories, and has secured patents to strengthen its product portfolio. Financially, the company has nominal revenues and ongoing net losses, with a liquidity position supported by cash and current assets exceeding current liabilities. The company faces challenges related to Nasdaq listing compliance and market adoption of its products.

K2 Capital Acquisition Corp is a special purpose acquisition company incorporated in the Cayman Islands to pursue an initial business combination with one or more target businesses. The company has not yet selected a target or initiated substantive discussions. It focuses on technology sectors in northern Europe, targeting companies with enterprise valuations primarily between $150 million and $750 million. The management team has experience in SPAC transactions and aims to leverage its network to identify attractive targets. The company completed its IPO in January 2026, raising $138 million, which is held in a trust account. It has up to 18 months to complete a business combination, with possible extensions subject to shareholder approval. The company currently has no operations or employees beyond its officers.

Stark Focus Group, Inc. is a smaller reporting company with limited public disclosure of its business model and industry classification. The company has disclosed financial data through SEC filings, indicating ongoing operations with net income reported as of mid-2026. It faces liquidity challenges with zero cash on hand and current liabilities exceeding available liquid assets. The company plans to fund a proposed data center business and other ventures, relying on additional capital raises through equity or debt. No material legal proceedings or off-balance sheet arrangements have been reported. The company voluntarily discloses limited risk factors related primarily to capital raising and financing execution.

Creatd, Inc. is a development stage company with a limited operating history and early-stage revenue generation. The company reported a net loss of approximately $2.49 million for the six months ended June 30, 2026, and has an accumulated deficit of approximately $280.22 million. As of June 30, 2026, it held working capital of about $1.12 million, with current assets of $8.44 million and current liabilities of $7.32 million, resulting in a current ratio of 1.15 and a cash ratio of 0.67. The company is focused on monetizing its brands and expanding its user base but faces significant risks related to competition, user engagement, and operational execution.

Travelzoo operates as a global Internet media company focused on travel enthusiasts through its Travelzoo club, Jack's Flight Club, and Travelzoo META. It offers a paid membership model with negotiated travel deals and access to exclusive offers. The company generates revenue from advertising fees paid by travel and entertainment companies, transaction-based commerce including voucher sales and hotel bookings, and membership fees. Travelzoo licenses its products in select Asia-Pacific markets, earning royalties. The business is segmented into North America, Europe, Jack's Flight Club, and New Initiatives. The company recognizes revenue according to the nature of the service, with advertising revenues recognized over contracted periods or upon delivery, and transaction-based revenues reported net of merchant payments and estimated refunds. Travelzoo invests in mobile and metaverse offerings to enhance its product portfolio. The company has experienced fluctuations in profitability and cash flows, with recent net losses reported in 2026. It maintains a share repurchase program authorized by its board.

Lumexa Imaging Holdings, Inc. is a company operating in the medical products sector, as indicated by recent industry outlook reports and analyst coverage. The company has publicly available earnings call transcripts for Q1 and Q2 2026, which provide insights into its operational performance and strategic direction. Financial disclosures from the latest 10-Q filing as of June 30, 2026, show a solid liquidity position with a current ratio of 1.44 and positive net income for the quarter. The company is subject to typical industry legal risks, including professional liability litigation, but management does not expect these to materially impact the business. Market commentary reflects both challenges from industry headwinds and interest from analysts regarding the stock's potential.

Skinvisible, Inc. operates through its subsidiary Skinvisible Pharmaceuticals Inc. as a pharmaceutical research and development company focused on topical skin products enhanced by its proprietary polymer delivery system, Invisicare®. The company targets large global markets in skincare, dermatology, and emerging medical areas such as obesity. Its business model centers on out-licensing patented products and technology to established manufacturers worldwide, supplemented by co-development services and life cycle management of products coming off patent. Key partnerships include an exclusive license agreement with Quoin Pharmaceuticals for the development and commercialization of QRX003, a product in late-stage clinical trials for Netherton Syndrome, and a license agreement with Ovation Science for hand sanitizer products and cannabinoid-based topical formulations. Skinvisible has filed provisional patents for transdermal delivery systems targeting obesity and glucose control. The company faces financial challenges with limited revenue, net losses, and low liquidity, alongside competitive and regulatory risks.

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products globally. The company operates through three segments: Core Nutritional, which is the largest and geographically segmented into Asia Pacific and Americas and Europe; Hiya, a direct-to-consumer children's health products provider acquired in 2024; and Rise, acquired in 2022, offering wellness products in North America. USANA distributes products through an omni-channel platform including direct selling, direct-to-consumer, third-party marketplaces, and retail. The company maintains significant operations in China through its subsidiary BabyCare, which operates under a business model tailored to Chinese regulations but not yet government-approved. USANA's financial position as of mid-2026 shows a strong liquidity profile with a current ratio of 2.66 and cash equivalents of $168.56 million. The company reported a net loss in Q2 2026, impacted by goodwill impairment and increased operating expenses. USANA faces regulatory scrutiny in direct selling, including FTC oversight in the US and regulatory risks in China and other international markets. The company also manages risks related to Brand Partner compliance, product manufacturing, international trade, and data security.

AltEnergy Acquisition Corp is a blank check company (SPAC) incorporated in Delaware in 2021. Its sole purpose is to identify and complete an initial business combination with one or more target businesses. The company has not commenced operations or generated revenue. It completed its IPO in November 2021, raising approximately $230 million in gross proceeds, which are held in a trust account invested primarily in U.S. government securities and mutual funds. The company has extended the deadline to complete its initial business combination multiple times, with the current deadline set for May 1, 2026. The company was delisted from Nasdaq due to failure to complete the business combination within the required timeframe and now trades on the OTC Pink Open Market. The company has no full-time employees and minimal operating expenses, primarily related to administrative costs and interest expenses. Its financial condition depends on completing the initial business combination or winding up operations.

Sundance Strategies, Inc. is a company engaged in the life settlements market, historically focused on acquiring life insurance policies and residual interests such as net insurance benefits (NIBs) from portfolios held by third parties. The company currently does not hold policies directly but provides professional advisory services to structured finance groups, bond issuers, and life settlement aggregators. It uses proprietary analytics to structure bonds backed by life settlement assets and managed cash, acting as sole originator and advisor in bond offerings. The company follows strict guidelines for advising on life settlement purchases, including insured age criteria, policy types, financing coverage, and due diligence processes. It operates in a competitive environment with larger financial institutions and insurance companies. As of March 31, 2026, the company had one full-time employee and makes its SEC filings publicly available on its website.

Permian Basin Royalty Trust (PBT) is a royalty trust that owns overriding royalty interests in oil and natural gas properties primarily located in the Permian Basin. The Trust receives royalty payments based on production from these properties but does not operate the underlying assets. It is governed by a Trustee, Argent Trust Company, and does not have directors or officers. The Trust regularly issues monthly cash distributions to unitholders. Recently, a proposed business combination has been announced involving a significant unitholder, SoftVest, and Blackbeard Holdings to create a new publicly traded entity, PBT Land and Minerals, Inc. This transaction is subject to unitholder approval and is not negotiated or recommended by the Trust or Trustee. The Trust's risk factors and legal proceedings are disclosed in its SEC filings, with no material changes reported in recent quarterly updates.

San Juan Basin Royalty Trust is a royalty trust that holds royalty interests carved from Hilcorp's oil and natural gas assets in the San Juan Basin. The trust receives income from production on these interests and distributes cash to unit holders when operational and market conditions allow. The trust is managed by Argent Trust Company as trustee and trades on the NYSE under the ticker SJT.

Magyar Bancorp, Inc. is a Delaware-chartered stock holding company whose primary business is ownership of Magyar Bank. Magyar Bank attracts retail deposits and invests these funds in a diversified loan portfolio including one-to four-family residential mortgage loans, commercial real estate loans, home equity loans, commercial business loans, and construction loans. The company’s financial performance is mainly driven by net interest income, which depends on interest rate environments, loan and deposit mix, and prepayment rates. As of June 30, 2026, total assets were approximately $1.048 billion, with loans receivable totaling $890 million, predominantly commercial real estate loans. The company has demonstrated growth in loans and deposits, improved net interest margins, and maintained strong asset quality with minimal non-performing loans. Liquidity is managed through cash, investment securities, deposit inflows, and borrowings, with borrowing capacity from the Federal Home Loan Bank of New York. The company also engages in share repurchases and dividend payments as part of capital management.

Presidio Property Trust, Inc. is a publicly traded, internally-managed REIT incorporated in Maryland, with a diversified portfolio of commercial real estate assets including office, industrial, retail, and model home properties. The company owns 10 commercial properties and has partial interests in two additional properties through affiliates. Its commercial properties are located in Colorado, North Dakota, California, Maryland, and Texas, while model home properties are leased back to homebuilders in four states. The company focuses on acquiring stabilized or near-stabilized properties in regionally dominant U.S. markets with strong economic fundamentals. Leases are typically triple-net, with commercial leases averaging three to five years and model home leases two to three years. The company manages its model home business through affiliated limited partnerships and wholly-owned subsidiaries that provide management services and receive fees. It actively evaluates its portfolio for value appreciation and disposes of underperforming assets to reinvest in higher potential properties.

HCM IV Acquisition Corp. is a Cayman Islands exempted blank check company formed to effect a business combination with one or more target businesses. The company completed its IPO in February 2026, raising net proceeds placed in a trust account invested in U.S. government securities or money market funds. The company has not commenced operations or selected a target as of the latest filings. Its management team focuses on acquiring established businesses of scale with growth potential. The company provides public shareholders redemption rights upon completion of a business combination. The Sponsor holds founder shares and has agreed to support the business combination process.

Crown Equity Holdings, Inc. is a Nevada-incorporated company originally established in 1995. It previously owned subsidiaries providing voice over internet services, direct sales, and real estate holdings, all sold in 2017. Currently, the company offers consulting services to domestic and international clients aiming to become public entities in the United States. It operates a network of websites focused on online media advertising, marketing, and news dissemination, targeting companies seeking market awareness. The company is compensated in cash and/or stock of client companies. It is actively working to increase its online readership and attract advertisers to strengthen its competitive position in the online publishing industry. The company’s operations include utilizing independent contractors and maintaining office space provided at no charge by an officer or director [S1].

Tecogen Inc. produces commercial and industrial natural gas engine-driven combined heat and power (CHP) products that reduce energy costs and greenhouse gas emissions. The company operates three segments: Products, which designs and sells cogeneration and chiller systems; Services, which provides operations and maintenance under long-term contracts; and Energy Production, which owns and operates distributed generation systems and sells energy under long-term agreements. Tecogen's products are highly efficient, with systems exceeding 88% efficiency and typically halving greenhouse gas emissions compared to the electrical grid. Customers span hospitals, educational institutions, commercial buildings, food processors, and indoor agriculture. The company has shipped over 3,200 units, some operating for nearly 35 years. Tecogen is focusing growth efforts on artificial intelligence data centers, addressing power constraints with its natural gas cooling and on-site power generation solutions. The company has a partnership with Vertiv Corporation to market its chillers for data center cooling applications globally. Tecogen also develops hybrid-drive air-cooled chillers that blend grid and natural gas power sources for cost savings and resiliency. The company completed a significant equity offering in 2025 to fund product development and expansion into the data center market. Recent quarters have seen declines in product sales but growth in services and energy production revenues. Tecogen maintains a strong liquidity position with a current ratio near 3 as of mid-2026.

Omega Flex, Inc. manufactures flexible metal hose, fittings, and accessories used in various industries including construction, manufacturing, transportation, petrochemical, and pharmaceutical sectors. The company operates a single segment focused on flexible metal hose products, with key product lines such as TracPipe® CSST and CounterStrike® CSST flexible gas piping systems and the newer MediTrac® corrugated medical tubing for healthcare facilities. Manufacturing is conducted in the U.S. and U.K., and sales are primarily through independent sales organizations and distributors across North America and select international markets. The company holds a broad portfolio of patents and trademarks supporting its competitive position. Recent product branding changes include rebranding CounterStrike® CSST as TracPipe® AP CSST and introducing a re-engineered fitting to enhance safety and installation ease. The company received CE mark certification for its MediTrac® product line in 2026. Omega Flex faces competition from larger firms and is exposed to risks from raw material cost fluctuations, reliance on independent sales channels, and product liability litigation.

Socket Mobile, Inc. designs, manufactures, and markets mobile data capture products aimed at business mobility markets. Its product portfolio includes Bluetooth cordless barcode scanners, NFC & RFID contactless reader/writers certified by major payment and technology standards, and camera-based barcode scanning solutions. The company supports app developers through its CaptureSDK to integrate data capture capabilities into mobile applications. Distribution is global, relying on key distributors such as Ingram Micro®, ScanSource®, and Blue Star, as well as online resellers. The company emphasizes product durability, ergonomic design, and ease of use for mobile workers. Intellectual property protections include patents and trademarks. The company had 53 employees as of the end of 2025, with personnel across sales, engineering, finance, and operations. Financially, the company reported revenue of $3.03 million and a net loss of $1.35 million for the quarter ended June 30, 2026, with liquidity ratios below 1, indicating current liabilities exceed current assets.

Global Crossing Airlines Group Inc. (GlobalX) operates a US Part 121 domestic flag and supplemental airline using Airbus A320 family aircraft. The company offers two main service types: ACMI (Aircraft, Crew, Maintenance, and Insurance) wet lease contracts to other airlines, and Full Service Charter passenger flights charging an all-inclusive fee. GlobalX operates primarily from Miami International Airport with additional operations in Texas, Louisiana, and Arizona. The company had a fleet of sixteen passenger aircraft and four cargo aircraft as of December 31, 2025, with plans to expand the passenger fleet to twenty-one aircraft within 12 months. GlobalX's revenue is primarily derived from ACMI contracts and Charter services, with one customer accounting for approximately 50% of total revenue in 2025. The company is subject to extensive federal regulation including FAA certification and environmental laws.

Harvard Apparatus Regenerative Technology, Inc. operates in the regenerative medicine sector, focusing on developing implantable products for esophageal and other tissue regeneration. The company is engaged in clinical trials and research collaborations with academic and medical institutions. It has reported recurring operating losses and an accumulated deficit, reflecting its development-stage status. The company’s financial position as of mid-2026 shows limited liquidity with current liabilities exceeding current assets. It has recognized share-based compensation expenses contingent on milestone achievements. The company’s lead product has received orphan disease designation in Europe, supporting its clinical development pathway.

Mentor Capital, Inc. was founded in 1985 as an investment partnership and reincorporated in Delaware in 2015. It operates primarily as a holding and management company providing consultation and administrative functions for its subsidiaries. The company has a strategic focus on classic energy sectors such as oil, gas, coal, and uranium, and maintains gold investments as a placeholder while arranging new energy positions. In 2023 and 2025, Mentor Capital acquired fractional, non-operating royalty interests in over 120 wells in the Permian Basin, Texas, entitling it to revenue shares without operational responsibilities. The company divested its 51% interest in Waste Consolidators Inc. in 2023 to concentrate on energy investments. It also holds residual investments in legal dispute resolution and annuity-like financing. The company has two full-time employees and relies on external professional support. It faces competition from well-funded companies in the energy investment space and operates in a complex regulatory and market environment. Mentor Capital's common stock trades on the OTCQB market and is not listed on any exchange.

Sentinel Holdings Ltd. is a Nevada-based holding company conducting business through its subsidiaries Sentry Protective Services, Inc., United Security Specialists Inc. (formerly owned), and Gladiator Solutions Inc. The company provides professional security personnel and services including on-site protection, mobile patrol, and event security primarily in California. Gladiator Solutions previously produced personal protective equipment but has suspended operations due to litigation. Sentinel has pursued a growth strategy focused on acquisitions and expansion of services, integrating technology such as smartphone applications and planning to incorporate advanced technologies like drones and AI. The company faces significant competition and pricing pressures in the private security market, which is large and growing. Sentinel reported revenue of approximately $2.1 million and a net loss of $1.1 million for Q2 2026, with liquidity ratios indicating current liabilities exceed current assets. The company continues to seek additional capital to fund growth and acquisitions.

Provectus Biopharmaceuticals, Inc. develops immunotherapy medicines using a proprietary pharmaceutical-grade active ingredient, rose bengal sodium (RBS). The company is the first to advance RBS into clinical trials and to produce it at nearly 100% purity. Its drug platform includes multiple clinical development programs targeting cancers, dermatological conditions, and eye diseases, alongside proof-of-concept and early discovery programs in various therapeutic areas. Manufacturing processes comply with cGMP and have regulatory acceptance. The company is pre-revenue and reports ongoing net losses.

Target Group Inc. operates in the Canadian cannabis industry, focusing on wholesale and co-packaging services for cannabis consumer-packaged goods. The company integrates cannabinoid research, analytical testing, product development, and manufacturing. Its product portfolio includes cannabis flower and extract pods for vaporizers, pre-rolls, infused beverages, edibles, topical products, and CBD wellness items. The company owns licensed production facilities through subsidiaries such as Visava Inc./Canary Rx Inc., which operates a 44,000 square foot facility in Ontario with capacity to grow up to 4 million grams annually. Target Group also acquired CannaKorp Inc., which developed a patented vaporizer system. The company holds exclusive distribution and licensing rights for Serious Seeds B.V.'s proprietary cannabis seed strains in Canada and other legal markets. Financially, the company reported a net loss and low liquidity ratios as of mid-2026, reflecting ongoing operational and financial challenges. The company does not have U.S. operations and is subject to regulatory risks inherent in the cannabis industry.

Cross Timbers Royalty Trust (CRT) holds net profits interests in oil and gas properties, primarily owned and operated by XTO Energy, a wholly owned subsidiary of ExxonMobil. The Trust's income is derived from net profits interests, which represent a share of revenues from oil and gas production after deducting certain costs such as production expenses, taxes, and development costs. The Trust distributes monthly cash income to unitholders based on net profits income received, less administrative expenses. The Trust does not engage in business activities beyond holding these interests and short-term cash investments. The Trust's financial statements are prepared on a modified cash basis, recognizing income when received and expenses when paid, consistent with SEC guidance for royalty trusts. The Trust's net profits interests are amortized on a unit-of-production basis using proved reserves. The Trust maintains a cash reserve for contingencies and may borrow funds to pay liabilities if repaid before distributions. The Trust has no directors or officers; Argent Trust Company serves as Trustee. The Trust's income and distributions are influenced by oil and gas sales volumes, prices, and costs, with natural production decline and market volatility affecting results.

Sky Quarry Inc. operates the Eagle Springs Refinery near Ely, Nevada, producing diesel, vacuum gas oil, naphtha, and asphalt products from regional crude oil. The company also develops the PR Spring Facility in Utah to recycle waste asphalt shingles and remediate oil-saturated sands using its proprietary ECOSolv solvent-based technology, which recovers up to 99% of solvent and achieves up to 95% oil separation in bench tests. The PR Spring Facility retrofit is underway to enable commercial operations, with plans to develop modular recycling facilities to process shingles near manufacturing centers. The company’s revenue streams include refined petroleum products and recycled asphalt materials. Sky Quarry faces customer concentration risks and liquidity challenges, with recurring losses and outstanding debt in default. Strategic initiatives include crowdfunding, digital asset treasury, and partnerships to expand recycling and refining capacity [S1][S2][N1][N2][N3].

Free Flow USA, Inc. was incorporated in 2011 and initially focused on green energy solutions, particularly solar panels for agricultural water pumps in India and Pakistan. Early efforts in solar energy and pharmaceuticals did not generate significant revenues. The company has since diversified into scrap metal processing, auto parts recycling, and real estate investment through various subsidiaries. It has acquired and later divested assets in auto parts recycling due to financing challenges. The company has no current sales backlog or government contracts and operates with a small team supplemented by consultants. Its capital structure includes common and preferred shares with complex voting rights. Recent strategic moves include agreements to purchase a steel plant in Morocco and real estate investment properties, as well as an initial agreement to acquire a pharmaceutical business. The company has reported modest revenues and ongoing net losses, with financial statements prepared under the assumption of going concern but noting substantial doubt about its ability to continue without additional capital or revenue growth [S1, S2, N7, N8].

GENELUX Corp is a late clinical-stage biopharmaceutical company focused on developing next-generation oncolytic viral immunotherapies targeting aggressive and difficult-to-treat tumors. Its lead product candidate, Olvi-Vec, is a genetically modified vaccinia virus designed to selectively kill tumor cells and stimulate a personalized immune response. Olvi-Vec is being evaluated in multiple clinical trials, including a Phase 3 registrational trial in platinum-resistant/refractory ovarian cancer in the U.S., a Phase 2 trial in recurrent non-small cell lung cancer, and a Phase 1b/2 trial in recurrent small cell lung cancer in China. The company has an exclusive license agreement with Newsoara BioPharma for development and commercialization in China. GENELUX operates its own cGMP manufacturing facility in San Diego, producing clinical and potential commercial supplies of Olvi-Vec. The company has not yet generated revenue from product sales and continues to incur operating losses as it advances clinical development and prepares for potential commercialization [S1][S2].